secwatch.observer — SEC 8-K summary
======================================

Issuer:     HERON THERAPEUTICS, INC. /DE/ (HRTX)
CIK:        0000818033
Form:       8-K
Filed at:   2026-06-16T18:49:30+00:00
Accession:  0001193125-26-272388
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Stockholders approve all 6 proposals at 2026 Annual Meeting including equity plan increases
--------------------------------------------------------------------------------

- All 7 director nominees elected; Mr. Waage had lowest For votes at ~85.3M, broker non-votes ~50.1M.
- Ratification of Withum Smith+Brown as auditor: 139.7M For, 1.7M Against, 0.5M Abstain.
- Say-on-pay passed nonbinding advisory: 77.3M For, 12.1M Against, 2.4M Abstain.
- Equity incentive plan amended to add 16.56M shares: 75.6M For, 13.8M Against.
- ESPP amended to add 10M shares (83.8M For); Tax Benefits Preservation Plan ratified (88.2M For).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/818033/000119312526272388/0001193125-26-272388-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/818033/000119312526272388/hrtx-20260611.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-272388

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer